Atezolizumab in First Line NSCLC: Early Clinical Results from the IMpower150 Trial (BMIC-020) - 102204

Spotlight
Video

Atezolizumab in First Line NSCLC: Early Clinical Results from the IMpower150 Trial (BMIC-020)

BeaconMedIC has 71 videos Subscribe Here

Loading........
Description: Dr. Jack West reviews the preliminary clinical results on the IMpower150 trial that tested the value of adding the immune checkpoint inhibitor atezolizumab to carbo/paclitaxel/bevacizumab in patients with chemo-naïve advanced non-squamous NSCLC.
Shared By : BeaconMedIC
Posted on : 12/18/17
Added : 1 year ago
Category : Immunotherapy